Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin [4]

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4425-4426

  Qamruddin, Ahmed O ^a   Alkawash, Mustafa A ^b   Soothill, James S ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CHLORAMPHENICOL; GENTAMICIN; LACTOFERRIN; RIFAMPICIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; RECOMBINANT PROTEINS; RIFAMPIN; STENOTROPHOMONAS MALTOPHILIA;

EID: 25844443585     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4425-4426.2005     Document Type: Letter

References (10)

1. Acocella, G. 1983. Pharmacokinetics and metabolism of rifampin in humans. Rev. Infect. Dis. 5(Suppl. 3):428-432.
2. Alkawash, M., M. Head, and J. S. Soothill. 1999. MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains are lower in the presence of human lactoferrin. J. Antimicrob. Chemother. 44:385-387.
3. Chen, P. W., S. P. Ho, C. L. Shyu, and F. C. Mao. 2004. Effect of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs. Am. J. Vet. Res. 65:131-137.
4. Denny, B., P. West, and D. Panigrahi. 2003. Effects of permeabilizers on antimicrobial susceptibility of Stenotrophomonas maltophilia and Acinetobacter spp. J. Microbiol. Immunol. Infect. 31:72-76.
5. Denton, M. 1997. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:15-19.
6. Ellison, R. T., T. J. Ghiel, and F. M. LaForce. 1988. Damage to the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56:2774-2781.
7. Fowler, C. E., J. S. Soothill, and L. Oakes. 1997. MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present. J. Antimicrob. Chemother. 40:877-879.
8. Giamarellos-Bourboulis, E. J., L. Karnesis, and H. Giamarellou. 2002. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multi-drug-resistant Stenotrophomonas maltophilia. Diagn. Microbiol. Infect. Dis. 44:259-263.
9. Jacquot, J., J. M. Tournier, T. G. Carmona, E. Puchelle, J. P. Chazalett, and E. Sadoul. 1983. Proteins of bronchial secretions in mucoviscidosis. Role in infection. Bull. Eur. Physiopathol. Respir. 19:453-459. (In French.)
10. Naidu, A. S., and R. R. Arnold. 1994. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. Diagn. Microbiol. Infect. Dis. 20:69-75.